[Federal Register Volume 82, Number 68 (Tuesday, April 11, 2017)]
[Notices]
[Pages 17437-17438]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-07188]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Secretary; Notice of Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
Muscular Dystrophy Coordinating Committee (MDCC).
The meeting will be open to the public and accessible by live
webcast. Attendance is limited to space available. Individuals who plan
to attend and need special assistance, such as sign language
interpretation or other reasonable accommodations, should notify the
Contact Person listed below in advance of the meeting.
Name of Committee: Muscular Dystrophy Coordinating Committee.
Type of meeting: Open Meeting.
Date: June 19, 2017.
Time: 8:30 a.m. to 4:30 p.m. *Eastern Time*--Approximate end
time.
Agenda: The purpose of this meeting is to bring together
committee members, representing government agencies, patient
advocacy groups, other voluntary health organizations, and patients
and their families to update one another on progress relevant to the
Action Plan for the Muscular Dystrophies and to coordinate
activities and discuss gaps and opportunities leading to better
understanding of the muscular dystrophies, advances in treatments,
and improvements in patients' and their families' lives. Prior to
the meeting, an agenda will be posted to the MDCC meeting
registration Web site: https://meetings.ninds.nih.gov/meetings/MDCC19June2017/.
Registration: To register, please go to: https://meetings.ninds.nih.gov/meetings/MDCC19June2017/.
Webcast Live: For those not able to attend in person, this
meeting will be webcast at: http://videocast.nih.gov/.
Place: Neuroscience Center, Conference Room C/D, 6001 Executive
Boulevard, Rockville, Maryland 20852.
Contact Person: Glen H. Nuckolls, Ph.D., Executive Secretary,
Muscular Dystrophy Coordinating Committee, National Institute of
Neurological Disorders and Stroke, NIH, 6001 Executive Boulevard,
NSC 2203, Bethesda, MD 20892, (301) 496-5745,
[email protected].
Any member of the public interested in presenting oral comments
to the committee may notify the Contact Person listed on this notice
at least 10 days in advance of the meeting. Interested individuals
and representatives of organizations may submit a letter of intent,
a brief description of the organization represented, and a short
description of the oral presentation. Only one representative of an
organization may be allowed to present oral comments and if accepted
by the committee, presentations may be limited to five minutes. Both
printed
[[Page 17438]]
and electronic copies are requested for the record. In addition, any
interested person may file written comments with the committee by
forwarding their statement to the Contact Person listed on this
notice. The statement should include the name, address, telephone
number and when applicable, the business or professional affiliation
of the interested person.
All visitors must go through a security check at the building
entrance to receive a visitor's badge. A government issued photo ID
is required. Further information can be found at the registration
Web site: https://meetings.ninds.nih.gov/meetings/MDCC19June2017/.
(Catalogue of Federal Domestic Assistance Program Nos. 93.853,
Clinical Research Related to Neurological Disorders; 93.854,
Biological Basis Research in the Neurosciences, National Institutes
of Health, HHS)
Dated: April 5, 2017.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-07188 Filed 4-10-17; 8:45 am]
BILLING CODE 4140-01-P